Occudo Quantitative Strategies’s Innoviva INVA Stock Holding History

Occudo Quantitative Strategies’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-56,683	Closed	-$1.14M	–	759
2025 Q2	$1.14M	Buy	+56,683	New	+$1.09M	0.13%	211
2025 Q1	–	Sell	-21,999	Closed	-$382K	–	776
2024 Q4	$382K	Buy	+21,999	New	+$422K	0.07%	372
2024 Q1	–	Sell	-98,682	Closed	-$1.58M	–	887
2023 Q4	$1.58M	Buy	+98,682	New	+$1.38M	0.22%	131
2023 Q1	–	Sell	-56,243	Closed	-$745K	–	1039
2022 Q4	$745K	Sell	56,243 -49,611	-47%	-$652K	0.09%	376
2022 Q3	$1.23M	Buy	105,854 +84,786	+402%	+$1.16M	0.1%	326
2022 Q2	$311K	Sell	21,068 -16,488	-44%	-$270K	0.03%	780
2022 Q1	$727K	Buy	+37,556	New	+$671K	0.06%	502

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Occudo Quantitative Strategies's INVA Position: Q3 2025 in Review

Occudo Quantitative Strategies sold out of Innoviva (INVA) in Q3 2025, closing a stake of 56,683 shares — an estimated $1.14M sold.

Occudo Quantitative Strategies first reported a position in INVA in Q1 2022 and held it in 7 quarters. The position peaked at $1.58M in Q4 2023. 264 funds tracked by Wall St. Rank hold INVA as of Q3 2025.

Occudo Quantitative Strategies reported no remaining Innoviva position as of Q3 2025 after selling out during the quarter.
Occudo Quantitative Strategies sold 56,683 Innoviva shares in Q3 2025, an estimated $1.14M.
Occudo Quantitative Strategies first reported a position in Innoviva in Q1 2022 and held it in 7 quarters.
Occudo Quantitative Strategies's Innoviva position peaked at $1.58M in Q4 2023.
264 funds tracked by Wall St. Rank held Innoviva as of Q3 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.